Skip to main content
. 2019 Dec 5;8(12):1577. doi: 10.3390/cells8121577

Figure 1.

Figure 1

Onset of aGvHD and number of MSC infusions. (A) Median overall aGvHD onset was 30 days (range 6–280 days). (B) Median number of doses of MSC-FFM was 3 (range: 1–9), with the majority receiving either 2 or, as intended per label, 4 doses.